Shabana Kokeb, kausar Inayat, Sajjad Ahmad, Arfa Tabassum


Background: Endometriosis is common gynecological condition of women in reproductive age. The objective of the study was to compare the level of CA-125 in patients with endometriosis before and after surgical treatment.
Material & Methods: This cross-sectional study was conducted in the Department of Gynecology and obstetrics, PIMS, Islamabad, Pakistan from February 2012 to March 2013. Sample size was 100. The sampling technique was consecutive non probability. The demographic variables were age and age group. The research variables were parity and level of CA-125. All baseline investigations, CA125 level and pelvic USG were performed. Percentage and frequency for categorical variables like age group and parity were calculated. Mean ±SD of numeric variables like age and level of CA-125 were calculated. Mean change was calculated in CA-125 levels by using paired sample t-test. All collected data was analyzed by using SPSS version 10.
Results: The mean age of the sample was 29.4±5.5 years. Out of total 100 women 78% of the women were between 26 to 40 years of age, 4% were upto 20 years whereas 5% were above 41 years of age. Out of total 100 study cases, 53% were nulliparous, 10% were primiparous while 37% of the women were found to be multiparous. The pre operative mean CA-125 level was 60.5±46.4 IU/ml while post operatively after 6 weeks it was 27.5±17.5 IU/ml and this difference between pre operative and post operative CA-125 levels was statistically significant(p-value=<0.001).
Conclusion: Level of CA-125 decreases markedly in patients with endometriosis after undergoing operative therapy.


Endometriosis, CA-125 levels, Surgery; Treatment.

Full Text:



Nezhat C, King LP, Paka C, Odegaard J, Beygui R. Bilateral Thoracic Endometriosis Affecting the Lung and Diaphragm. JSLS 2012;16:140-2.

Mahmud G, Akhtar T, Sadia S. Endometriosis: frequency and correlation between symptomatology and disease stage; J Coll Physicians Surg Pak 2007;17:199-202.

Appleyard T, Mann C, Khan K. Guidelines for the management of pelvic pain associated with Endometriosis: a systemic appraisal of their quality. BJOG 2006;113:749-57.

Management of Endometriosis. Practice Bulletin No.14. The American college of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:223-36.

Lossal K, Loft A, Freiesleben NL, Bangsboll S, Andersen CY, Pedersen AT et al. Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriosis-A pilot study. Eur J Obstet Gynecol Reprod Biol 2009;144:48-53.

Maiorana A, Cicerone C, Niceta M, Alia L. Evaluation of CA125 levels in patients with pelvic pain related to endometriosis. Int J Biol Marker 2007;22:200-2.

Marana R, Muzih L, Muscatello P, Lanzone A, Caruso A, Dell SA et al. Gonadotrophin releasing hormones agonist (buserelin ) in the treatment of endometriosis; change in the extent of disease and in CA-125 serum level after 6-month therapy. BJOG 1990;97:1016-9.

Moore RG, Milller MC, Steinhoff MM, Skates SJ, Lu KH, Lambert-Messerlian G et al. Serum HE4 levels are less frequently elevated than CA-125 in women with benign gynecologic disorders. Am J Obstet Gynecol 2012;206:351.e1-8.

Garzetti GG, Ciyattini A, Tranguillin AL, Arduini D, Romanini C. Serum CA-125 concentration in endometriosis patients. Role of pelvic and peritoneal irritation. Gynecol Endocrinol 1994;8:27-31.

Chen FP, Soong YK, Lee N, Lo SK. The use of serum CA-125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand 1998;77:665-70.

Jacobs I, Bast RC Jr. The CA-125 tumour-associated antigen: a review of the literature. Hum Reprod 1989;4:1-12.

Ghaemmaghami F, Karimi Zarchi M, Hamedi B. High levels of CA-125 (over 1,000 IU/ml) in patients with gynecologic disease and no malignant conditions: three cases and literature review. Arch Gynecol Obstet 2007;276:559-61.

American College of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice. The role of the generalist obstetrician–gynecologist in the early detection of ovarian cancer. Gynecol Oncol 2002;87:237-9.


  • There are currently no refbacks.

Copyright (c) 2020 Shabana Kokeb, kausar Inayat, Sajjad Ahmad, Arfa Tabassum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.